Predicate |
Object |
assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_0bbef4f6fed6600c9dfa488b4f846726 |
classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K47-60 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-193 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-04 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-535 |
classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-08 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-02 |
classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-113 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P31-00 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K47-48 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-22 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K- http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-535 |
filingDate |
2004-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
grantDate |
2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_c597c942ec4c79e3c6f2cde56bf82637 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_296fec20e75c974e2b17f2bffdd7ddab http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7ce3b4502286f79e882ceba9e8ea4596 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2582d78ccf3401ac857ed97751326ada http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_38473346dcab5e30ba2adbdbae86db53 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bb8d191b23bd48f965fdaccd5f26bac4 http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d5c5bc5bd0d559b8ef7fc0819bc8a305 |
publicationDate |
2013-10-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
publicationNumber |
CA-2549409-C |
titleOfInvention |
Glycopegylated granulocyte colony stimulating factor |
abstract |
The present invention provides conjugates between Granulocyte Colony Stimulating Factor and PEG moieties. The conjugates are linked via an intact glycosyl linking group that is interposed between and covalently attached to the peptide and the modifying group. The conjugates are formed from both glycosylated and unglycosylated peptides by the action of a glycosyltransferase. The glycosyltransferase ligates a modified sugar moiety onto either an amino acid or glycosyl residue on the peptide. Also provided are pharmaceutical formulations including the conjugates. Methods for preparing the conjugates are also within the scope of the invention. |
priorityDate |
2003-12-03-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
type |
http://data.epo.org/linked-data/def/patent/Publication |